The weekly litigation news digest is live. Subscribe now

IP Verse

Treatment Of Obesity, The Metabolic Syndrome, Type 2 Diabetes, Cardiovascular Diseases, Dementia, Alzheimer'S Disease And Inflammatory Bowel Disease By Using At Least One Bacterial Strain From Prevotella - EP3016527

The patent EP3016527 was granted to Proprev on Jul 25, 2018. The application was filed on May 27, 2014 under application number EP14808269A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3016527

PROPREV
Application Number
EP14808269A
Filing Date
May 27, 2014
Status
Opposition Rejected
Jun 16, 2023
Publication Date
Jul 25, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
DUPONT NUTRITION BIOSCIENCES APSApr 24, 2019N&H EMEA -

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTCN102744320
OPPOSITIONWO0207741
OPPOSITIONWO2004009103
OPPOSITIONWO2010122106
OPPOSITIONWO2012089783
OPPOSITIONWO2012142605
SEARCHCN102743420
SEARCHWO2011053653
SEARCHWO2012142605
SEARCHWO2013053836

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents